STRATEC Biomedical Valuation
| SRBZF Stock | USD 72.96 0.00 0.00% |
At this time, the company appears to be fairly valued. STRATEC Biomedical has a current Real Value of $72.96 per share. The regular price of the company is $72.96. Our model measures the value of STRATEC Biomedical from evaluating the company fundamentals such as gross profit of 67.5 M as well as inspecting its technical indicators and probability of bankruptcy.
STRATEC Biomedical Total Value Analysis
STRATEC Biomedical AG is at this time forecasted to have takeover price of 946.79 M with market capitalization of 946.79 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the STRATEC Biomedical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
946.79 M | 946.79 M |
STRATEC Biomedical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of STRATEC implies not a very effective usage of assets in October.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates STRATEC Biomedical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in STRATEC Biomedical and how it compares across the competition.
About STRATEC Biomedical Valuation
The pink sheet valuation mechanism determines STRATEC Biomedical's current worth on a weekly basis. Our valuation model uses a comparative analysis of STRATEC Biomedical. We calculate exposure to STRATEC Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of STRATEC Biomedical's related companies.8 Steps to conduct STRATEC Biomedical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates STRATEC Biomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct STRATEC Biomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain STRATEC Biomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine STRATEC Biomedical's revenue streams: Identify STRATEC Biomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research STRATEC Biomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish STRATEC Biomedical's growth potential: Evaluate STRATEC Biomedical's management, business model, and growth potential.
- Determine STRATEC Biomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate STRATEC Biomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for STRATEC Pink Sheet analysis
When running STRATEC Biomedical's price analysis, check to measure STRATEC Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STRATEC Biomedical is operating at the current time. Most of STRATEC Biomedical's value examination focuses on studying past and present price action to predict the probability of STRATEC Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STRATEC Biomedical's price. Additionally, you may evaluate how the addition of STRATEC Biomedical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |